Oral Mineralocorticoid-Receptor Antagonists: Real-Life Experience in Clinical Subtypes of Nonresolving Central Serous Chorioretinopathy With Chronic Epitheliopathy.

Transl Vis Sci Technol · 2016 · PMC4782825 · PMID 26966638

Europe PMC DOI

hedged sentences

0.0580

closest p · 1.2× alpha

0.0580

boldest claim

The sentences

near-significantP = 0.058so close (0.05 < p ≤ 0.1)

In persistent cases with tracks, a near-significant decrease in foveal SRF was observed after 6 months of treatment ( P = 0.058; Fig. 2 ).

also in 2,306 other papers

failed to achieve significanceno p-value reported

Patients presenting persistent CSCR with tracks showed a moderate improvement that failed to achieve significance due to the limited number of subjects.

also in 299 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.